[go: up one dir, main page]

FI941574L - Kemiallisia yhdisteitä - Google Patents

Kemiallisia yhdisteitä Download PDF

Info

Publication number
FI941574L
FI941574L FI941574A FI941574A FI941574L FI 941574 L FI941574 L FI 941574L FI 941574 A FI941574 A FI 941574A FI 941574 A FI941574 A FI 941574A FI 941574 L FI941574 L FI 941574L
Authority
FI
Finland
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Application number
FI941574A
Other languages
English (en)
Swedish (sv)
Other versions
FI105035B (fi
FI941574A0 (fi
Inventor
Are Dalen
Finn Myhren
Bernt Boerretzen
Kjell Torgeir Stokke
Original Assignee
Norsk Hydro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro As filed Critical Norsk Hydro As
Publication of FI941574A0 publication Critical patent/FI941574A0/fi
Publication of FI941574L publication Critical patent/FI941574L/fi
Application granted granted Critical
Publication of FI105035B publication Critical patent/FI105035B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • External Artificial Organs (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI941574A 1991-10-07 1994-04-06 Menetelmä uuden, terapeuttisesti aktiivisen monoesteriyhdisteen valmistamiseksi FI105035B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9121257 1991-10-07
GB9121257A GB2260319B (en) 1991-10-07 1991-10-07 Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
PCT/NO1992/000162 WO1993007163A1 (en) 1991-10-07 1992-09-30 Chemical compounds
NO9200162 1992-09-30

Publications (3)

Publication Number Publication Date
FI941574A0 FI941574A0 (fi) 1994-04-06
FI941574L true FI941574L (fi) 1994-04-06
FI105035B FI105035B (fi) 2000-05-31

Family

ID=10702531

Family Applications (2)

Application Number Title Priority Date Filing Date
FI990270A FI990270L (fi) 1991-10-07 1992-09-30 Uuden monoesteriyhdisteet
FI941574A FI105035B (fi) 1991-10-07 1994-04-06 Menetelmä uuden, terapeuttisesti aktiivisen monoesteriyhdisteen valmistamiseksi

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI990270A FI990270L (fi) 1991-10-07 1992-09-30 Uuden monoesteriyhdisteet

Country Status (26)

Country Link
US (1) US6548486B1 (fi)
EP (1) EP0642525B1 (fi)
JP (1) JP2873313B2 (fi)
KR (1) KR100272732B1 (fi)
AT (1) ATE152454T1 (fi)
CA (1) CA2120725C (fi)
CH (1) CH0642525H1 (fi)
CZ (1) CZ288153B6 (fi)
DE (1) DE69219482T2 (fi)
DK (1) DK0642525T3 (fi)
FI (2) FI990270L (fi)
GB (1) GB2260319B (fi)
GR (1) GR3024149T3 (fi)
HU (1) HU219400B (fi)
IL (1) IL103351A (fi)
MX (1) MX9205715A (fi)
NO (1) NO300014B1 (fi)
NZ (1) NZ244535A (fi)
PL (1) PL170846B1 (fi)
RU (1) RU2126417C1 (fi)
SG (1) SG47759A1 (fi)
SK (1) SK281903B6 (fi)
TW (1) TW347333B (fi)
UA (1) UA41296C2 (fi)
WO (1) WO1993007163A1 (fi)
ZA (1) ZA927432B (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9307043D0 (en) * 1993-04-05 1993-05-26 Norsk Hydro As Chemical compounds
US5869493A (en) 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
GB2321455A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Lipophilic derivatives of biologically active compounds
RU2178710C1 (ru) * 2001-02-08 2002-01-27 Кожемякин Леонид Андреевич Индивидуальные вещества, полученные на основе химического взаимодействия дисульфидсодержащих пептидов с производными пуриновых или пиримидиновых оснований, фармацевтические композиции и препараты на их основе, способы их применения для лечения инфекционных заболеваний и профилактики осложнений
RU2328273C2 (ru) * 2001-12-19 2008-07-10 Рисерч Дивелопмент Фаундейшн Липосомальная доставка соединений, основанных на витамине е
GB0201179D0 (en) * 2002-01-18 2002-03-06 Angeletti P Ist Richerche Bio Therapeutic agents
TWI332507B (en) 2002-11-19 2010-11-01 Hoffmann La Roche Antiviral nucleoside derivatives
WO2006101911A1 (en) 2005-03-16 2006-09-28 Case Western Reserve University Selective inhibitors of translesion dna replication
WO2008147454A1 (en) * 2006-11-16 2008-12-04 Case Western Reserve University Selective inhibitors of translesion dna replication
NO324263B1 (no) * 2005-12-08 2007-09-17 Clavis Pharma Asa Kjemiske forbindelser, anvendelse derav ved behandling av kreft, samt farmasoytiske preparater som omfatter slike forbindelser
EP1962808B1 (en) * 2005-12-14 2010-09-29 F. Hoffmann-La Roche AG Hcv prodrug formulation
US8497292B2 (en) 2005-12-28 2013-07-30 Translational Therapeutics, Inc. Translational dysfunction based therapeutics
US20090111774A1 (en) * 2007-06-01 2009-04-30 Luitpold Pharmaceuticals, Inc. Pmea lipid conjugates
EP2175863B1 (en) 2007-07-09 2018-03-21 Eastern Virginia Medical School Substituted nucleoside derivatives with antiviral and antimicrobial properties
BRPI0817269A2 (pt) * 2007-09-26 2014-10-07 Sinai School Medicine Análogos de azacitidina e usos dos mesmos
US9988680B2 (en) 2011-09-01 2018-06-05 Case Western Reserve University Non-natural nucleosides as theranostic agents
US9493500B2 (en) 2012-07-19 2016-11-15 Richard Daifuku Fluorinated pyrimidine analogs and methods of use thereof
US9821173B2 (en) 2013-02-08 2017-11-21 Case Western Reserve University Anti-cancer agents and methods of use
RU2561501C1 (ru) * 2014-08-05 2015-08-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) Федеральный Университет" (ФГАОУ ВПО КФУ) Антиретровирусные препараты на основе производных азидотимидина
RU2621145C2 (ru) * 2015-11-03 2017-05-31 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежский государственный университет" (ФГБОУ ВПО "ВГУ") Способ получения липосом
JP2021515771A (ja) * 2018-03-07 2021-06-24 グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ （Ｎｏ．２） Ｌｉｍｉｔｅｄ Ｈｉｖ療法に有用な化合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920630A (en) * 1970-09-24 1975-11-18 Upjohn Co 2,2{40 -Anhydro-ara-cytidine compounds and process of preparation
GB1325797A (en) * 1970-09-24 1973-08-08 Upjohn Co Medicines comprising cytidine derivatives
US4211773A (en) * 1978-10-02 1980-07-08 Sloan Kettering Institute For Cancer Research 5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
DE3100478A1 (de) * 1981-01-09 1982-08-12 Dr. Thilo & Co GmbH, 8021 Sauerlach 5'ester von pyrimidinnucleosiden mit antiviraler wirksamkeit, verfahren zur herstellung und daraus hergestellte arzneimittel
US4355032B2 (en) 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4816447A (en) 1981-08-26 1989-03-28 Merck & Co., Inc. Anti-viral guanine compounds
NZ201662A (en) 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation
US5250535A (en) * 1982-02-01 1993-10-05 Syntex Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
US4556659A (en) * 1982-08-09 1985-12-03 Syntex (U.S.A.) Inc. Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted propoxymethyl)-purines as antiviral agents
JPH0655755B2 (ja) * 1985-01-23 1994-07-27 富山化学工業株式会社 新規な５−フルオロ−２′−デオキシウリジン−３′−ホスフエ−ト誘導体およびその塩
US4684631A (en) 1984-10-09 1987-08-04 Toyama Chemical Co., Ltd. Novel 5-fluoro-2-deoxyuridine derivatives and salts thereof, process for producing the same, and antitumor agents containing the same
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
EP0202056B1 (en) * 1985-05-07 1989-08-30 Teijin Limited Antitumor agent
JPS6483092A (en) * 1987-09-24 1989-03-28 Arakawa Chotaro & Co Novel n6,n6-dimethyladenosine derivative having carcinostatic activity, its production and carcinostatic agent containing said derivative as active component
ZA888083B (en) * 1987-10-28 1990-06-27 Pro Neuron Inc Acyl deoxyribonucleoside derivatives and uses thereof
JPH0278696A (ja) * 1988-09-13 1990-03-19 Shoichiro Ozaki ５−フルオロウラシル誘導体
IE980216A1 (en) * 1989-04-17 2000-02-23 Scotia Holdings Plc Anti-virals
FI105556B (fi) * 1991-09-30 2000-09-15 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten pyrimidiiniukleosidijohdannaisten valmistamiseksi, joilla on kasvaimen vastaista vaikutusta

Also Published As

Publication number Publication date
CA2120725C (en) 2000-04-11
DE69219482D1 (de) 1997-06-05
MX9205715A (es) 1993-05-01
FI990270A0 (fi) 1999-02-10
NO941269L (no) 1994-04-07
HK1007430A1 (en) 1999-04-09
HU219400B (hu) 2001-04-28
CH0642525H1 (en) 1999-06-30
FI105035B (fi) 2000-05-31
KR100272732B1 (ko) 2000-11-15
ZA927432B (en) 1993-06-09
GB9121257D0 (en) 1991-11-20
HU9400988D0 (en) 1994-07-28
DE69219482T2 (de) 1997-10-23
PL170846B1 (en) 1997-01-31
AU2867392A (en) 1993-05-03
SK39794A3 (en) 1994-10-05
ATE152454T1 (de) 1997-05-15
SK281903B6 (sk) 2001-09-11
FI941574A0 (fi) 1994-04-06
EP0642525A1 (en) 1995-03-15
SG47759A1 (en) 1998-04-17
GB2260319A (en) 1993-04-14
RU2126417C1 (ru) 1999-02-20
DK0642525T3 (da) 1997-11-03
JP2873313B2 (ja) 1999-03-24
GR3024149T3 (en) 1997-10-31
IL103351A (en) 2000-02-17
EP0642525B1 (en) 1997-05-02
NO941269D0 (no) 1994-04-07
CZ80594A3 (en) 1994-12-15
HUT68008A (en) 1995-05-29
GB2260319B (en) 1995-12-06
US6548486B1 (en) 2003-04-15
WO1993007163A1 (en) 1993-04-15
IL103351A0 (en) 1993-03-15
FI990270A7 (fi) 1999-02-10
JPH06511249A (ja) 1994-12-15
AU672369B2 (en) 1996-10-03
TW347333B (en) 1998-12-11
UA41296C2 (uk) 2001-09-17
NO300014B1 (no) 1997-03-17
CZ288153B6 (en) 2001-05-16
NZ244535A (en) 1995-08-28
FI990270L (fi) 1999-02-10
CA2120725A1 (en) 1993-04-15

Similar Documents

Publication Publication Date Title
FI922424A7 (fi) Kemiallisia yhdisteitä
MX9101375A (es) Compuestos quimicos
FI944078A7 (fi) Kemiallisia yhdisteitä
FI893751A7 (fi) Kemialliset yhdisteet
FI955587A0 (fi) Kemialliset yhdisteet
FI941574L (fi) Kemiallisia yhdisteitä
FI930773A7 (fi) En kemisk process
FI911286A7 (fi) Kemialliset yhdisteet
FI894648A7 (fi) Kemiallisia yhdisteitä
MX9202262A (es) Compuestos quimicos.
FI922423A7 (fi) Kemiallisia yhdisteitä
FI945907L (fi) Kemiallisia yhdisteitä
FI922170L (fi) Kemisk process
FI923757L (fi) Kemisk process
FI910059A7 (fi) Kemialliset yhdisteet
FI925259L (fi) Kemiskt foerfarande
NO930791D0 (no) Substituerte tinnsilikatforbindelser
MX9205851A (es) Compuestos quimicos
FI920668A7 (fi) Oksatsinobentsatsoliyhdisteet
DK244090D0 (da) Kemiske forbindelser
DK150591D0 (da) Kemisk forbindelse
FI940890L (fi) Uusia yhdisteitä
MX9206711A (es) Compuestos quimicos
FI943637L (fi) Aryylialkoksifenoksi-imidatsoliiniyhdisteitä
DK144591D0 (da) Kemisk forbindelse

Legal Events

Date Code Title Description
MA Patent expired